Fabrication and functional attributes of lipidic nanoconstructs of lycopene: An innovative endeavour for enhanced cytotoxicity in MCF-7 breast cancer cells

Colloids and Surfaces B: Biointerfaces

Volumn 152, Issue , 2017, Pages 482-491

  Jain, Ashay ^a,b   Sharma, Gajanand ^a   Kushwah, Varun ^c   Thakur, Kanika ^a   Ghoshal, Gargi ^b   Singh, Bhupinder ^b   Jain, Sanyog ^c   Shivhare, U S ^b   Katare, O P ^a  

^a PANJAB UNIVERSITY   (India)

^b PANJAB UNIVERSITY   (India)

^c NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Breast cancer; Cytotoxicity; Lycopene; Methotrexate; Solid lipid nanoparticles

Indexed keywords

BIOCOMPATIBILITY; CELL CULTURE; CELL DEATH; CYTOLOGY; CYTOTOXICITY; DISEASES; NANOPARTICLES;

ANTICANCER POTENTIALS; BREAST CANCER; LYCOPENES; MCF-7 BREAST CANCER CELLS; METHOTREXATE; NANOSTRUCTURED PARTICLES; SOLID LIPID NANOPARTICLE (SLN); THERAPEUTIC BENEFITS;

CELLS;

BIOMATERIAL; GELUCIRE; GLYCEROL BEHENATE; LYCOPENE; METHOTREXATE; SOLID LIPID NANOPARTICLE; ANTINEOPLASTIC AGENT; CAROTENOID; DRUG CARRIER; LIPID; NANOPARTICLE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG POTENTIATION; DRUG UPTAKE; HUMAN; HUMAN CELL; IN VITRO STUDY; MCF-7 CELL LINE; NANOFABRICATION; CHEMISTRY; DRUG EFFECTS; FEMALE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CAROTENOIDS; CELL SURVIVAL; DRUG CARRIERS; FEMALE; HUMANS; LIPIDS; MCF-7 CELLS; METHOTREXATE; NANOPARTICLES;

EID: 85012050864     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2017.01.050     Document Type: Article

References (37)

1. [1] Bennett, L.L., Rojas, S., Seefeldt, T., Role of antioxidants in the prevention of cancer. J. Exp. Clin. Med. 4 (2012), 215–222.
2. [2] Klaunig, J.E., Kamendulis, L.M., The role of oxidative stress in carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 44 (2004), 239–267.
3. [3] Jain, S., Spandana, G., Agrawal, A.K., Kushwah, V., Thanki, K., Enhanced antitumor efficacy and reduced toxicity of docetaxel loaded estradiol functionalized stealth polymeric nanoparticles. Mol. Pharm. 12 (2015), 3871–3884.
4. [4] Lehár, J., Krueger, A.S., Avery, W., Heilbut, A.M., Johansen, L.M., Price, E.R., et al. Synergistic drug combinations tend to improve therapeutically relevant selectivity. Nat. Biotechnol. 27 (2009), 659–666.
5. [5] Keith, C.T., Borisy, A.A., Stockwell, B.R., Multicomponent therapeutics for networked systems. Nat. Rev. Drug Discov. 4 (2005), 71–78.
6. [6] Kaelin, W.G., The concept of synthetic lethality in the context of anticancer therapy. Nat. Rev. Cancer 5 (2005), 689–698.
7. [7] Martello, L.A., McDaid, H.M., Regl, D.L., Yang, C.P., Meng, D., Pettus, T.R., et al. Taxol and discodermolide represent a synergistic drug combination in human carcinoma cell lines. Clin. Cancer Res. 6 (2000), 1978–1987.
8. [8] Calabrò, F., Lorusso, V., Rosati, G., Manzione, L., Frassineti, L., Sava, T., et al. Gemcitabine and paclitaxel every 2 weeks in patients with previously untreated urothelial carcinoma. Cancer 115 (2009), 2652–2659.
9. [9] Jain, A.K., Thanki, K., Jain, S., Co-encapsulation of tamoxifen and quercetin in polymeric nanoparticles: implications on oral bioavailability, antitumor efficacy, and drug-induced toxicity. Mol. Pharm. 10 (2013), 3459–3474.
10. [10] Khan, N., Afaq, F., Mukhtar, H., Cancer chemoprevention through dietary antioxidants: progress and promise. Antioxid. Redox Signal. 10 (2008), 475–510.
11. [11] Glade, M.J., Food, nutrition, and the prevention of cancer: a global perspective. American Institute for Cancer Research/World Cancer Research Fund, American Institute for Cancer Research, 1997. Nutrition 15 (1999), 523–526.
12. [12] Evans, J.L., Antioxidants: do they have a role in the treatment of insulin resistance?. Indian J. Med. Res. 125 (2007), 355–372.
13. [13] Giovannucci, E., Rimm, E.B., Liu, Y., Stampfer, M.J., Willett, W.C., A prospective study of tomato products lycopene, and prostate cancer risk. J. Natl. Cancer Inst. 94 (2002), 391–398.
14. [14] Dorgan, J.F., Sowell, A., Swanson, C.A., Potischman, N., Miller, R., Schussler, N., et al. Relationships of serum carotenoids, retinol, alpha-tocopherol, and selenium with breast cancer risk: results from a prospective study in Columbia Missouri (United States). Cancer Causes Control 9 (1998), 89–97.
15. [15] Jain, A., Thakur, D., Ghoshal, G., Katare, O.P., Singh, B., Shivhare, U.S., Formation and functional attributes of electrostatic complexes involving casein and anionic polysaccharides: an approach to enhance oral absorption of lycopene in rats in vivo. Int. J. Biol. Macromol. 93 (2016), 746–756.
16. [16] Jain, A., Kesharwani, P., Garg, N.K., Jain, A., Jain, S.A., Jain, A.K., et al. Galactose engineered solid lipid nanoparticles for targeted delivery of doxorubicin. Colloids Surf. B Biointerfaces 134 (2015), 47–58.
17. [17] Jain, A., Agarwal, A., Majumder, S., Lariya, N., Khaya, A., Agrawal, H., et al. Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug. J. Controlled Release 148 (2010), 359–367.
18. [18] Jain, A.K., Jain, A., Garg, N.K., Jain, A., Jain, S.A., Tyagi, R.K., et al. Adapalene loaded solid lipid nanoparticles gel: an effective approach for acne treatment. Colloids Surf. B Biointerfaces 121 (2014), 222–229.
19. [19] Jain, A., Thakur, D., Ghoshal, G., Katare, O.P., Shivhare, U.S., Microencapsulation by complex coacervation using whey protein isolates and gum acacia: an approach to preserve the functionality and controlled release of β-carotene. Food Bioprocess Technol. 8 (2015), 1635–1644.
20. [20] Garg, N.K., Singh, B., Jain, A., Nirbhavane, P., Sharma, R., Tyagi, R.K., et al. Fucose decorated solid-lipid nanocarriers mediate efficient delivery of methotrexate in breast cancer therapeutics. Colloids Surf. B Biointerfaces 146 (2016), 114–126.
21. [21] Kolhe, P., Misra, E., Kannan, R.M., Kannan, S., Lieh-Lai, M., Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers. Int. J. Pharm. 259 (2003), 143–160.
22. [22] Pauwels, B., Korst, A.E.C., de Pooter, C.M.J., Pattyn, G.G.O., Lambrechts, H.A.J., Baay, M.F.D., et al. Comparison of the sulforhodamine B assay and the clonogenic assay for in vitro chemoradiation studies. Cancer Chemother. Pharmacol. 51 (2003), 221–226.
23. [23] Squier, M.K., Cohen, J.J., Standard quantitative assays for apoptosis. Mol. Biotechnol. 19 (2001), 305–312.
24. [24] Vermes, I., Haanen, C., Steffens-Nakken, H., Reutellingsperger, C., A novel assay for apoptosis flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods 184 (1995), 39–51.
25. [25] Negi, L.M., Jaggi, M., Talegaonkar, S., Development of protocol for screening the formulation components and the assessment of common quality problems of nano-structured lipid carriers. Int. J. Pharm. 461 (2014), 403–410.
26. [26] Aburahma, M.H., Badr-Eldin, S.M., Compritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticals. Expert Opin. Drug Deliv. 11 (2014), 1865–1883.
27. [27] Bose, S., Du, Y., Takhistov, P., Michniak-Kohn, B., Formulation optimization and topical delivery of quercetin from solid lipid based nanosystems. Int. J. Pharm. 441 (2013), 56–66.
28. [28] Cavallari, C., Rodriguez, L., Albertini, B., Passerini, N., Rosetti, F., Fini, A., Thermal and fractal analysis of diclofenac/Gelucire 50/13 microparticles obtained by ultrasound-assisted atomization. J. Pharm. Sci. 94 (2005), 1124–1134.
29. [29] de Oliveira Eloy, J., Saraiva, J., de Albuquerque, S., Marchetti, J.M., Solid dispersion of ursolic acid in Gelucire 50/13: a strategy to enhance drug release and trypanocidal activity. AAPS PharmSciTech 13 (2012), 1436–1445.
30. [30] Kharya, P., Jain, A., Gulbake, A., Shilpi, S., Jain, A., Hurkat, P., et al. Phenylalanine-coupled solid lipid nanoparticles for brain tumor targeting. J. Nanopart. Res., 15, 2013, 2022.
31. [31] Jain, A., Garg, N.K., Jain, A., Kesharwani, P., Jain, A.K., Nirbhavane, P., et al. A synergistic approach of adapalene-loaded nanostructured lipid carriers, and vitamin C co-administration for treating acne. Drug Dev. Ind. Pharm. 42 (2016), 897–905.
32. [32] Yu, H., Huang, Q., Investigation of the cytotoxicity of food-grade nanoemulsions in Caco-2 cell monolayers and HepG2 cells. Food Chem. 141 (2013), 29–33.
33. [33] Jain, A.K., Swarnakar, N.K., Godugu, C., Singh, R.P., Jain, S., The effect of the oral administration of polymeric nanoparticles on the efficacy and toxicity of tamoxifen. Biomaterials 32 (2011), 503–515.
34. [34] Greish, K., Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines. J. Drug Target. 15 (2008), 457–464.
35. [35] Garg, N.K., Singh, B., Sharma, G., Kushwah, V., Tyagi, R.K., Jain, S., et al. Development and characterization of single step self-assembled lipid polymer hybrid nanoparticles for effective delivery of methotrexate. RSC Adv. 5 (2015), 62989–62999.
36. [36] Schoepf, U., Marecos, E.M., Melder, R.J., Jain, R.K., Weissleder, R., Intracellular magnetic labeling of lymphocytes for in vivo trafficking studies. Biotechniques 24:642–646 (1998), 648–651.
37. [37] Miglietta, A., Cavalli, R., Bocca, C., Gabriel, L., Rosa Gasco, M., Cellular uptake and cytotoxicity of solid lipid nanospheres (SLN) incorporating doxorubicin or paclitaxel. Int. J. Pharm. 210 (2000), 61–67.